Gene · 654
Papers3,545
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,545
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity. | Front Oncol | 2022 | 35547872 | PubTator, text mining | PubMed |
| RPS27 selectively regulates the expression and alternative splicing of inflammatory and immune response genes in thyroid cancer cells. | Adv Clin Exp Med | 2022 | 35546566 | PubTator, text mining | PubMed |
| The transcriptome-wide N6-methyladenosine (m6A) map profiling reveals the regulatory role of m6A in the yak ovary. | BMC Genomics | 2022 | 35538402 | PubTator, text mining | PubMed |
| Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability. | Nat Commun | 2022 | 35534486 | PubTator, text mining | PubMed |
| Canonical Bone Morphogenetic Protein Signaling Regulates Expression of Aquaporin-4 and Its Anchoring Complex in Mouse Astrocytes. | Front Cell Neurosci | 2022 | 35518645 | PubTator, text mining | PubMed |
| Dental applications of induced pluripotent stem cells and their derivatives. | Jpn Dent Sci Rev | 2022 | 35516907 | PubTator, text mining | PubMed |
| Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. | J Clin Invest | 2022 | 35511419 | PubTator, text mining | PubMed |
| POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells. | Br J Cancer | 2022 | 35501388 | PubTator, text mining | PubMed |
| Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma. | Front Oncol | 2022 | 35494000 | PubTator, text mining | PubMed |
| New Insights Into Pathophysiology of β-Thalassemia. | Front Med (Lausanne) | 2022 | 35492364 | PubTator, text mining | PubMed |
| Integrated regulation of chondrogenic differentiation in mesenchymal stem cells and differentiation of cancer cells. | Cancer Cell Int | 2022 | 35488254 | PubTator, text mining | PubMed |
| Sequential activation of M1 and M2 phenotypes in macrophages by Mg degradation from Ti-Mg alloy for enhanced osteogenesis. | Biomater Res | 2022 | 35484564 | PubTator, text mining | PubMed |
| OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor. | Signal Transduct Target Ther | 2022 | 35484112 | PubTator, text mining | PubMed |
| Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. | Immunity | 2022 | 35483355 | PubTator, text mining | PubMed |
| New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis. | Circ Res | 2022 | 35482831 | PubTator, text mining | PubMed |
| Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma. | Front Genet | 2022 | 35480307 | PubTator, text mining | PubMed |
| NFκB inhibition to lift the mechano-competence of mesenchymal stromal cell-derived neocartilage toward articular chondrocyte levels. | Stem Cell Res Ther | 2022 | 35477424 | PubTator, text mining | PubMed |
| Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn's Disease. | J Funct Biomater | 2022 | 35466218 | PubTator, text mining | PubMed |
| Two Modulators of Skeletal Development: BMPs and Proteoglycans. | J Dev Biol | 2022 | 35466193 | PubTator, text mining | PubMed |
| Ovarian Transcriptomic Analysis of Ninghai Indigenous Chickens at Different Egg-Laying Periods. | Genes (Basel) | 2022 | 35456401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/654/papers?page=37